Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection.
Milnacipran is an antidepressant drug belonging to the class of serotonin and noradrenaline reuptake inhibitors. A sensitive high performance liquid chromatographic during the development method coupled with a fluorimetric detection was set up, validated and then used routinely of the drug. After liquid-liquid extraction, milnacipran and its internal standard were analyzed by reversed-phase liquid chromatography (LC). The drug was derivatized with fluorescamine for fluorescence detection. The identity of the liquid chromatography peaks was controlled using mass spectrometry. The assay linearity was validated up to 1000 ng/ml. The limit of quantification was set at 5 ng/ml. Precision values (relative standard deviations) were lower than 5.4%, whereas the mean accuracy was higher than 95%. The extraction recoveries were higher than 70% for both milnacipran and the internal standard. In clinics, the LC-fluorescence method was routinely used to investigate the pharmacokinetics of milnacipran in patients and proved to be robust and capable of quantifying milnacipran in plasma for at least 36 h (four- to five-fold the elimination half-life).
Puozzo
Christian
C
Institut de Recherche Pierre Fabre, Oncology Clinical Pharmacokinetics Department, Castres, France.
Filaquier
Christian
C
Zorza
Grégoire
G
D002853:Chromatography, Liquid / Q000379:methods*; D003521:Cyclopropanes / Q000097:blood* / Q000493:pharmacokinetics; D005450:Fluorescamine / Q000737:chemistry; D006801:Humans; D000078764:Milnacipran; D009638:Norepinephrine / Q000378:metabolism*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D017367:Selective Serotonin Reuptake Inhibitors / Q000097:blood* / Q000493:pharmacokinetics; D013050:Spectrometry, Fluorescence / Q000379:methods*
D003521:Cyclopropanes; D005450:Fluorescamine; D000078764:Milnacipran; D009638:Norepinephrine; D017367:Selective Serotonin Reuptake Inhibitors